News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
278 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (3)
2 (185)
3 (278)
4 (284)
5 (141)
6 (1)
7 (33)
8 (301)
9 (160)
10 (89)
11 (101)
12 (45)
13 (2)
14 (4)
15 (29)
16 (183)
17 (128)
18 (141)
19 (58)
20 (1)
21 (2)
22 (121)
23 (156)
24 (136)
25 (116)
26 (49)
27 (2)
28 (2)
29 (148)
30 (159)
31 (160)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Genetown
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 42nd annual J.P. Morgan Healthcare Conference in San Francisco.
January 3, 2024
·
1 min read
Breakthrough in Treating Alzheimer’s Using Targeted Drug Delivery Reported in New England Journal of Medicine
A potential advancement in the treatment of Alzheimer’s disease was announced today by researchers at the West Virginia University Rockefeller Neuroscience Institute (RNI).
January 3, 2024
·
4 min read
Genetown
Cystic Fibrosis Rescued by Reprogramming the Cell’s Secretory Machinery
Porosome Therapeutics, Inc. announced the publishing of a study that brings promise for a cure to cystic fibrosis.
January 3, 2024
·
3 min read
Biotech Beach
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
Longboard Pharmaceuticals, Inc. announced the pricing of an upsized underwritten public offering of 10,000,000 shares of its voting common stock at a price to the public of $21.00 per share.
January 3, 2024
·
5 min read
Pharm Country
Laekna Announces Poster Presentation on Internally-Discovered Antibody for NASH/Liver Fibrosis at NASH-TAG 2024
Laekna announced that the company will present a novel therapeutical approach to treat liver fibrosis in the form of a poster at the NASH-TAG conference from January 4-6, 2024, in Park City, Utah.
January 3, 2024
·
4 min read
Biotech Bay
Medable to Present at 42nd Annual J.P. Morgan Healthcare Conference
Medable Inc. today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.
January 3, 2024
·
1 min read
Business
NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors
NorthStar Medical Radioisotopes, LLC and Curadh MTR Inc. announced a long-term strategic collaboration to develop and produce novel radiopharmaceuticals for the diagnosis and treatment of solid tumor cancers.
January 3, 2024
·
5 min read
Deals
Hera Biotech to Make First Acquisition in the Endometriosis Diagnostic Market and Enter Into Strategic Partnership With Scailyte
Hera Biotech announced today that it has reached an agreement to acquire the endometriosis diagnostic assets and associated IP of single-cell and AI-driven biomarker discovery company Scailyte, creating an important consolidation of the only two tissue-based diagnostic programs for endometriosis.
January 3, 2024
·
4 min read
BioCapital
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42th Annual J.P. Morgan Healthcare Conference.
January 3, 2024
·
1 min read
FDA Grants Breakthrough Device Designation for Geneseeq’s Multi-cancer Early Detection Solution
Geneseeq announced that its multi-cancer early detection solution, CanScan™, has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA).
January 3, 2024
·
1 min read
Previous
8 of 28
Next